Pulmatrix and Cipla Technologies have signed a definitive agreement to jointly develop and commercialise Pulmazole to treat allergic bronchopulmonary aspergillosis (ABPA) in asthma patients. Pulmazole is an inhaled iSPERSE (inhaled small particles easily respirable and emitted) […]
Boehringer Ingelheim has formed an alliance with US-based PureTech Health to develop new drug candidates for a variety of targets using lymphatic targeting technology. The research collaboration will initially work on Boehringer’s immuno-oncology candidate for […]
Gilead Sciences, Inc. and Novo Nordisk A/S today announced that the companies intend to collaborate on a clinical trial combining compounds from their respective pipelines in nonalcoholic steatohepatitis (NASH). The intended clinical trial will be […]
Pfizer has partnered with patient-centred research firm Concerto HealthAI to fast-track actionable patient insights for investigational and commercialised cancer therapies. The partnership will leverage Concerto HealthAI’s eurekaHealth platform, artificial intelligence (AI) models, Real World Clinical […]
Asklepios BioPharmaceutical (AskBio) has secured an investment of $235m to accelerate its business of developing and manufacturing Adeno-Associated Virus (AAV) gene therapies for rare and generally untreatable genetic disorders. The investment in AskBio includes an […]